Christa Springston
Internal Medicine · Tyrone, GANPI 1710010566
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,557 and has fallen 70.9% since, to $453 in 2025.
Across 245 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$698
- AstraZeneca$679
- Novo Nordisk$550
- Pfizer$381
- Amgen$337
- Lilly USA, LLC$229
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,02098%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $698 |
| AstraZeneca | 39 | $679 |
| Novo Nordisk | 38 | $550 |
| Pfizer | 16 | $381 |
| Amgen | 20 | $337 |
| Lilly USA, LLC | 10 | $229 |
| Astellas Pharma US Inc | 8 | $221 |
| Merck | 10 | $124 |
| Kowa Pharmaceuticals America, Inc. | 6 | $100 |
| Medtronic | 2 | $82 |
| Boehringer Ingelheim | 4 | $78 |
| Shire North American Group Inc | 5 | $71 |
| GSK | 4 | $60 |
| Hikma Pharmaceuticals USA | 3 | $56 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Novartis | 3 | $48 |
| Eisai Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Exact Sciences | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Dexcom, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Medline Industries LP | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $16 |
| Vertiflex, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,115 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 605 | $40,914 |
| EliquisApixaban | 12 | $17,466 |
| MounjaroTirzepatide | 13 | $13,651 |
| Yf-VaxYellow Fever Vaccine Live/Pf | 20 | $8,163 |
| Typhim ViTyphoid Vi Polysacch Vaccine | 28 | $6,324 |
| IpolPoliomyelitis Vaccine, Killed | 21 | $3,721 |
| VaqtaHepatitis A Virus Vaccine/Pf | 11 | $2,427 |
| Azithromycin | 407 | $1,238 |
| Doxycycline Hyclate | 28 | $491 |
| Sucralfate | 15 | $350 |
| Mirtazapine | 11 | $342 |
| Promethazine Hcl | 11 | $298 |
| Omeprazole | 18 | $199 |
| Escitalopram Oxalate | 14 | $199 |
| Atorvastatin Calcium | 16 | $183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $381 | $17,46612 claims |
| Lilly USA, LLCMounjaro | $229 | $13,65113 claims |
| MerckVaqta | $124 | $2,42711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Tyrone
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.